Literature DB >> 2745938

Factitious hypermineralcorticoidism by chronic use of 9-alpha-fluoroprednisolone containing collyrium.

M Errico, M Freda, M Zingrillo, M Grilli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2745938     DOI： 10.1007/BF03349987

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  4 in total

1.  The etiology of a syndrome of factitious mineralocorticoid excess: a steroid-containing nasal spray.

Authors:  J W Funder; W R Adam; F Mantero; N Kraft; S Ulick
Journal:  J Clin Endocrinol Metab       Date:  1979-12       Impact factor: 5.958

Review 2.  Ocular effects of topical and systemic corticosteroids.

Authors:  D S David; J S Berkowitz
Journal:  Lancet       Date:  1969-07-19       Impact factor: 79.321

3.  Factitious hypermineralocorticoidism due to transdermal application of a 9-alpha-prednisolone containing ointment.

Authors:  R Pedrinelli; A Lucarini; L Graziadei; S Taddei; A Salvetti
Journal:  J Endocrinol Invest       Date:  1985-08       Impact factor: 4.256

4.  Mineralocorticoid hypertension due to a nasal spray containing 9 alpha-fluoroprednisolone.

Authors:  F Mantero; D Armanini; G Opocher; F Fallo; L Sampieri; B Cuspidi; C Ambrosi; G Faglia
Journal:  Am J Med       Date:  1981-09       Impact factor: 4.965
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.